# Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer

> **NCT03855423** · NA · UNKNOWN · sponsor: **Nur Aishah Mohd Taib** · enrollment: 12 (estimated)

## Conditions studied

- Breast Cancer Female

## Interventions

- **DIETARY_SUPPLEMENT:** Tocotrienol-rich Fraction (TRF)

## Key facts

- **NCT ID:** NCT03855423
- **Lead sponsor:** Nur Aishah Mohd Taib
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-18
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2019-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03855423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03855423, "Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT03855423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*